CADDIE
Odin Medical Limited · Decision date Sep 12, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for CADDIE, a 510(k) submitted by Odin Medical Limited of London, on 12 September 2026; the application was received on 16 January 2026 under regulation 876.1520, product code QNP, in the Gastroenterology/Urology panel. SESE is a clearance, not a PMA approval. The public record lists the device classification as a gastrointestinal lesion software detection system and describes CADDIE as cloud-based artificial intelligence software that interfaces with an endoscopic video feed, limited to standard white-light endoscopy imaging.
The submission is a Special 510(k) addressing the introduction of a new compatible device, Arc Endocuff Vision, with performance testing described in the summary. The record does not state the predicate device, the specific testing results, or any clinical performance measures, so the basis for the equivalence finding beyond the compatible-device change remains unknown from these excerpts.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Sep 12, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260133
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Odin Medical Limited
- Product code
- QNP
- Decision code
- SESE
- Decision date
- Sep 12, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Gastrointesinal Lesion Software Detection System.
- Applicant
- Odin Medical Limited
- Product code
- QNP
- FDA device class
- 2
FDA decision timeline
K260133 received
Application receipt date recorded by FDA.
K260133 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Odin Medical Limited
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- London
Sources and methodology
- Original FDA record: K260133
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records